Integrated Advisors Network’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Buy |
4,153
+262
| +7% | +$18.3K | 0.01% | 622 |
|
|
2025
Q1 | $286K | Sell |
3,891
-2,556
| -40% | -$188K | 0.01% | 588 |
|
|
2024
Q4 | $422K | Sell |
6,447
-37,163
| -85% | -$2.43M | 0.02% | 493 |
|
|
2024
Q3 | $3.4M | Buy |
43,610
+13,860
| +47% | +$1.08M | 0.16% | 154 |
|
|
2024
Q2 | $2.32M | Buy |
29,750
+23,005
| +341% | +$1.79M | 0.12% | 185 |
|
|
2024
Q1 | $457K | Buy |
6,745
+232
| +4% | +$15.7K | 0.02% | 476 |
|
|
2023
Q4 | $439K | Buy |
6,513
+342
| +6% | +$23K | 0.02% | 470 |
|
|
2023
Q3 | $418K | Sell |
6,171
-16
| -0.3% | -$1.08K | 0.03% | 461 |
|
|
2023
Q2 | $443K | Sell |
6,187
-273
| -4% | -$19.5K | 0.03% | 463 |
|
|
2023
Q1 | $448K | Sell |
6,460
-14,395
| -69% | -$999K | 0.03% | 462 |
|
|
2022
Q4 | $1.41M | Buy |
20,855
+870
| +4% | +$59K | 0.09% | 235 |
|
|
2022
Q3 | $1.1M | Sell |
19,985
-59,260
| -75% | -$3.25M | 0.07% | 254 |
|
|
2022
Q2 | $5.24M | Buy |
79,245
+1,995
| +3% | +$132K | 0.34% | 75 |
|
|
2022
Q1 | $5.12M | Buy |
77,250
+1,806
| +2% | +$120K | 0.3% | 77 |
|
|
2021
Q4 | $4.4M | Buy |
75,444
+659
| +0.9% | +$38.4K | 0.26% | 103 |
|
|
2021
Q3 | $4.49M | Buy |
74,785
+59,025
| +375% | +$3.55M | 0.3% | 85 |
|
|
2021
Q2 | $944K | Sell |
15,760
-3,395
| -18% | -$203K | 0.07% | 231 |
|
|
2021
Q1 | $952K | Sell |
19,155
-29,439
| -61% | -$1.46M | 0.09% | 215 |
|
|
2020
Q4 | $2.43M | Sell |
48,594
-9,124
| -16% | -$456K | 0.27% | 108 |
|
|
2020
Q3 | $3.16M | Buy |
+57,718
| New | +$3.16M | 0.4% | 69 |
|